ALG

Alamo Group Inc.
$148.73
-1.93 (-1.28%)
Mkt Cap 1.81B
Volume 103,109
52W Range 145.76-219.88
Sector Industrials
Beta 1.08
EPS (TTM) 8.39 USD
P/E Ratio 17.73
Revenue (TTM) 1.66B USD
Rev Growth (5Y) +6.6%
EPS Growth (5Y) +12.0%
AlphaVal · Fair Value
What we estimate one share is worth
$214.98
Undervalued moderate signal
30.8% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Platform & Compounding FCF
67.2 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 1.60B 1.63B 1.69B 1.51B 1.33B 1.16B 1.12B 1.01B 912.38M 844.75M 879.58M 839.05M
Net Income 103.80M 115.93M 136.16M 101.93M 80.25M 57.80M 63.10M 73.49M 44.31M 40.05M 43.21M 41.15M
EPS 8.64 9.69 11.42 8.58 6.78 4.91 5.36 6.30 3.84 3.50 3.81 3.47
Free Cash Flow 146.92M 184.78M 93.41M (16.77M) 24.36M 166.46M 57.38M (13.79M) 57.31M 65.79M 37.08M 20.40M
FCF / Share 12.22 15.44 7.84 -1.41 2.06 14.13 4.89 -1.18 4.96 5.75 3.27 1.72
Operating CF 177.54M 209.78M 131.15M 14.53M 49.67M 184.33M 88.81M 12.91M 70.80M 75.55M 52.56M 30.21M
Total Assets 1.61B 1.45B 1.41B 1.31B 1.21B 1.12B 1.21B 721.63M 639.67M 552.78M 603.50M 629.60M
Total Debt 220.29M 226.93M 240.57M 306.64M 274.21M 289.07M 443.98M 85.30M 60.08M 70.09M 144.08M 190.57M
Cash & Equiv 309.66M 197.27M 51.92M 47.02M 42.12M 50.20M 42.31M 34.04M 25.37M 16.79M 26.92M 39.53M
Book Value 1.15B 1.02B 932.76M 785.36M 705.66M 635.00M 569.76M 507.37M 449.11M 387.72M 360.47M 337.67M
Return on Equity 0.09 0.11 0.15 0.13 0.11 0.09 0.11 0.14 0.10 0.10 0.12 0.12
ALG News
Alamo Group, Inc. (NYSE:ALG) Stock Now Rated “Moderate Buy” by Sell-Side Analysts
Oct 06, 2026 02:29 AM · defenseworld.net
ALAMO GROUP INC. DECLARES REGULAR QUARTERLY DIVIDEND
Oct 01, 2026 12:15 PM · prnewswire.com
Timken (NYSE:TKR) versus Alamo Group (NYSE:ALG) Head to Head Review
Sep 08, 2026 09:29 PM · defenseworld.net
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Aug 12, 2026 12:05 PM · globenewswire.com
Zacks Industry Outlook Deere, Kubota, CNH, AGCO and Alamo
Aug 05, 2026 02:46 AM · zacks.com
Alamo Group Inc. (ALG) Q2 2026 Earnings Call Transcript
Aug 04, 2026 03:50 PM · seekingalpha.com
Alamo Group Q2 Earnings Call Highlights
Aug 04, 2026 12:04 PM · marketbeat.com
5 Farm Equipment Stocks to Watch as Industry Shows Promise
Aug 04, 2026 09:36 AM · zacks.com
Alamo Group (ALG) Tops Q2 Earnings and Revenue Estimates
Aug 03, 2026 03:46 PM · zacks.com
ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER 2026
Aug 03, 2026 12:15 PM · prnewswire.com